EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

Journal of Diabetology

ISSN 2543-3288 · Ovid Technologies (Wolters Kluwer Health)

Latest articles

  1. The IQ-SET India Study: A Multicentric, Retrospective, Observational Data Analysis Evaluating the Safety, Efficacy, and Tolerability of InsuQuick® (Insulin Aspart 100 U/mL) in Subjects with Type 2 Diabetes Mellitus

    Supratik Bhattacharyya, Sudip Chatterjee, Abhijit A. Jadhav, Sreedevi Patnala, Rooban Chakravarthy, R. Anantharaman, Shrikant Somani, Harsha Pamnani, Purvi Chawla, Shivendra Verma, Paawan Wadhawan, G. S. Basavaraj, Kirti Samudra, R. Balamurugan, P. K. Gupta, Kishor Kharche, Amit Asalkar, Desu Nishitha, Rajat Gupta, V. R. Subbiah, Abhijit Bhograj, G. M. Prasad, M. Srinath, Balaji Jaganmohan, Amit Gupta

    Published: 2026-07DOI: 10.4103/jod.jod_202_25

  2. Consensus Guideline DTECH: Technology for Glycemic Control in Type 1 Diabetes

    Dhruvi Hasnani, Banshi Saboo, Sujoy Ghosh, Rakesh Parikh, Minal Mohit, Ghanshyam Das Ramchandani, Amit Gupta, Mithun Bhartia, Manoj Chawla, Rishi Shukla, Lotika Purohit, Hitesh Saraogi, Meghanad Meher, Rajnish Saxena, Vikranti Sailor, Sailesh Lodha, Anushree Mehta, Soumyaranjan Mohanty, Yusuf Bhambhani, Manoj Agrawal, Sanjay Popatlal Gandhi, Archana Sarda, Mahira Saiyed, Jothydev Kesavadev

    Published: 2026-07DOI: 10.4103/jod.jod_36_26

Volumes

2026 · 772025 · 562024 · 742023 · 472022 · 292021 · 101

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.